The overall findings suggest the roles of altered functions of AML1 imposed by some, but not all, mutants, and the elevated expression of wt.AML1 for the disease progression of CML. The gene discussed is RUNX1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.